Tribenzor (Olmesartan Medoxomil Amlodipine Hydrochlorothiazide Tablets) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - January 30, 2017 Category: Drugs & Pharmacology Source Type: news
Azor (Amlodipine and Olmesartan Medoxomil Tablets) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - December 28, 2016 Category: Drugs & Pharmacology Source Type: news
Lupin gets USFDA nod for hypertension treatment drug in US
Olmesartan medoximil tablets, generic version of Daiichi Sankyo's Benicar, are indicated for the treatment of hypertension, along with other anti-hypertensive agents. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 26, 2016 Category: Pharmaceuticals Source Type: news
Teva receives approval for generic Tribenzor in US
Teva Pharmaceutical Industries has secured approval for generic Tribenzor (olmesartan medoxomil, amlodipine and hydrochlorothiazide) tablets in the US and is in the last stages of launch preparation. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - November 9, 2016 Category: Pharmaceuticals Source Type: news
Ajanta Pharma launches BP lowering tablets in US
Ajanta Pharma's Amlodipine + Olmesartan Medoxomil tablets are a generic version of Daiichi Sankyo Inc's Azor tablets (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 2, 2016 Category: Pharmaceuticals Source Type: news
3 Drugs with the Most Severe Side Effects
Image Source
Drugs have been known to have some sort of side effects on patients. Most of them are not often discussed in the health tabloids. While other drugs have side effects that are very nominal when compared to the benefits the patient derives from their usage, others have side effects that can impact the lives of their users forever.
The most common side effects people experience from drug usage are gastrointestinal related issues which include constipation, nausea, and vomiting. Some other drugs can leave you feeling tired and dizzy for a short period of time. Combining these drugs with simple aspirin will usuall...
Source: Healthy Living - The Huffington Post - August 19, 2016 Category: Consumer Health News Source Type: news
Benicar HCT (Olmesartan Medoxomil-Hydrochlorothiazide) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - July 26, 2016 Category: Drugs & Pharmacology Source Type: news
Benicar (Olmesartan Medoxomil) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - July 26, 2016 Category: Drugs & Pharmacology Source Type: news
FDA Drug Safety Communication: Safety Review Update of Benicar (olmesartan) and cardiovascular events
This safety review update is in follow-up to the FDA Drug Safety Communication:Ongoing Safety Review of Benicar (olmesartan) and cardiovascular events on 6/11/2010. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - April 7, 2016 Category: Drugs & Pharmacology Source Type: news
FDA Drug Safety Communication: FDA approves label changes to include intestinal problems (sprue-like enteropathy) linked to blood pressure medicine olmesartan medoxomil
The U.S. Food and Drug Administration (FDA) is warning that the blood pressure drug olmesartan medoxomil (marketed as Benicar, Benicar HCT, Azor, Tribenzor, and generics) can cause intestinal problems known as sprue-like enteropathy. FDA has approved changes to the labels of these drugs to include this concern. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - February 26, 2016 Category: Drugs & Pharmacology Source Type: news
Comunicado de la FDA sobre la seguridad de los medicamentos: FDA aprueba cambios en la etiqueta para problemas intestinales (enteropatía similar a esprue) asociada con el medicamento olmesartán medoxomil para la presión alta
El 3 de julio, 2013, La Administración de Alimentos y Medicamentos de Estados Unidos (FDA por sus siglas en inglés) advirtió que el medicamento para la presión alta olmesartán medoxomil (comercializado como Benicar, Benicar HCT, Azor, Tribenzor y genéricos) ha sido asociado con problemas intestinales conocidos como enteropatía similar a esprue, y la agencia ha aprobado cambios en las etiquetas de estos medicamentos que mencionan esta inquietud. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - January 19, 2016 Category: Drugs & Pharmacology Source Type: news
U.S. top court allows Apotex to pursue generic version of Daiichi drug
WASHINGTON (Reuters) - The U.S. Supreme Court on Monday rejected appeals by Daiichi Sankyo Inc and Mylan Pharmaceuticals Inc seeking to stop Apotex Inc from trying to introduce a generic version of Benicar, a drug for treating hypertension. (Source: Reuters: Health)
Source: Reuters: Health - November 9, 2015 Category: Consumer Health News Tags: healthNews Source Type: news
New York Law Firm States That the FDA Announces Health Risks Involved...
New York Law Firm States That the FDA Announces Health Risks Involved with Patients Who Have Taken Benicar(PRWeb August 20, 2014)Read the full story at http://www.prweb.com/releases/2014/08/prweb12098612.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - August 21, 2014 Category: Pharmaceuticals Source Type: news
FDA Once Again Reaches Conclusions At Odds With Its Own Staff
Once again the FDA has reached a conclusion that is directly opposed by some of its own scientists. Last month the FDA affirmed the safety of olmesartan, a popular blood pressure lowering drug (sold as Benicar and other names). But that reassuring view is not shared by the FDA scientists who performed the study that provided the basis for the review. And now outside experts are also raising concerns about the drug. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - July 14, 2014 Category: Pharmaceuticals Authors: Larry Husten Source Type: news
FDA Alert Warns of Serious Intestinal Problems from Benicar, Azor and...
Have you experienced intestinal problems after taking Benicar, Azor or Tribenzor? There are current lawsuits being filed on behalf of victims.(PRWeb July 08, 2014)Read the full story at http://www.prweb.com/releases/Intestinal-Problems/Benicar-Azor-Tribenzor/prweb12001069.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - July 8, 2014 Category: Pharmaceuticals Source Type: news
